Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
41.62
+0.02 (0.05%)
At close: Jan 23, 2026

SHA:603014 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
3,6263,5353,4543,2942,778
Other Revenue
69.4969.4978.52131.76132.56
3,6953,6043,5323,4262,911
Revenue Growth (YoY)
4.62%2.04%3.09%17.71%-
Cost of Revenue
2,1882,0881,9901,9591,553
Gross Profit
1,5071,5161,5421,4671,358
Selling, General & Admin
781.25801.06857.25884.67841.65
Research & Development
148.49164.7154.86182.84153.49
Other Operating Expenses
35.1316.5832.0241.756.27
Operating Expenses
975.581,0211,0631,1351,007
Operating Income
531.71494.84478.99332.79350.7
Interest Expense
-0.4-0.6-0.85-18.33-47.58
Interest & Investment Income
40.9640.5729.0729.8318.86
Currency Exchange Gain (Loss)
2.732.732.387.533.63
Other Non Operating Income (Expenses)
-2.04-0.54-0.59-1.29-1
EBT Excluding Unusual Items
572.96536.99509.01350.53324.6
Gain (Loss) on Sale of Investments
0.890.220.11-2.18
Gain (Loss) on Sale of Assets
0.020.20.09-0.010.01
Asset Writedown
-3.29-2.75-3.65--7.8
Other Unusual Items
11.0211.0218.2515.320.31
Pretax Income
581.6545.68523.81365.84319.3
Income Tax Expense
107.2196.3181.7450.8859.48
Net Income
474.39449.37442.07314.96259.82
Net Income to Common
474.39449.37442.07314.96259.82
Net Income Growth
7.31%1.65%40.36%21.22%-
Shares Outstanding (Basic)
392370370364351
Shares Outstanding (Diluted)
392370370364351
Shares Change (YoY)
5.96%-1.76%3.63%-
EPS (Basic)
1.211.211.190.870.74
EPS (Diluted)
1.211.211.190.870.74
EPS Growth
1.32%1.68%37.47%16.98%-
Free Cash Flow
599.239355.33447.53103.64
Free Cash Flow Per Share
1.531.060.151.230.29
Gross Margin
40.79%42.06%43.67%42.83%46.65%
Operating Margin
14.39%13.73%13.56%9.71%12.05%
Profit Margin
12.84%12.47%12.52%9.19%8.93%
Free Cash Flow Margin
16.21%10.90%1.57%13.06%3.56%
EBITDA
764.25726.82710.24565.73542.22
EBITDA Margin
20.68%20.17%20.11%16.51%18.63%
D&A For EBITDA
232.54231.99231.25232.94191.52
EBIT
531.71494.84478.99332.79350.7
EBIT Margin
14.39%13.73%13.56%9.71%12.05%
Effective Tax Rate
18.43%17.65%15.60%13.91%18.63%
Revenue as Reported
3,6953,6043,5323,4262,911
Advertising Expenses
-24.4436.0446.0633.07
Source: S&P Global Market Intelligence. Standard template. Financial Sources.